Digital Hybrid and multi-cloud: The next step for biotech to secure ... An unmissable trend for those working in biotech research over the past decade has been the transition to cloud computing.
Market Access True innovation in life sciences is only possible through a ... Many of the biggest life sciences breakthroughs are the result of European research.
Digital Generative AI and its impact on speed to market for pharmace... Generative AI (GenAI) is revolutionising the life sciences, and we’re just scratching the surface.
Sales & Marketing Life sciences marketing ahead: Unveiling the role of AI-powe... The life sciences, just like any other industry, has been undergoing a paradigm shift, owing to rising digital adoption in the past few years.
R&D Scope for action: How the life sciences industry can make pr... With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.
R&D Investing in the gleams of positivity and hope for life scie... In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at Brit
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.